Form 4 for ASTH Astrana Health, Inc.

Accepted 2024-04-04 00:00:00 ET · period of report 2024-04-02 · accession 0001104659-24-043668 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
	2024-04-04	2024-04-02	ASTH	Sim Brandon	CEO, Pres	A - Grant	$0.00	+86.3K	988.9K	+10%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-04-02	A	A	86,305	$0.00	988,925	D	—	—	(F3) Represents a grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares shall vest in eight equal semi-annual installments beginning on October 2, 2024 (the six month anniversary of the grant date). (F4) Includes 668,584 shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 14,151 shares, which vest on November 2, 2024; (ii) 81,420 shares, which vest in three equal annual installments on June 27, 2024, 2025, and 2026; (iii) 8,335 shares, which vest in three equal annual installments on June 27, 2024, 2025, and 2026; (iv) 102,613 shares, which vest in six equal semi-annual installments, beginning September 30, 2024; and (v) 462,065 shares, which vest upon achievement of certain pre-established performance goals. Also includes 86,305 restricted stock units, which will vest in eight equal semi-annual installments beginning on October 2, 2024 (subject to continuous employment with the Issuer).